Never in my life had I felt so guilty and terrified," Dr. Ashley Joves told Newsweek, after spotting her husband's oral ...

Researchers from the University of Sheffield, working in collaboration with Fiocruz-Bahia in Brazil, are shedding new light ...

Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have been awarded three multi-year grants totaling $6 million ...

DelveInsight's Oropharyngeal Cancer Market Insights report includes a comprehensive understanding of current treatment ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...

CRT consisted of concomitant cisplatin (3 doses of 100 mg/m 2 every 3 weeks or 7 doses of 40 mg/m 2 every week) and radiotherapy (70 Gy in 35 fractions). A single dose of durvalumab (1500 mg) was ...

Many dedicated dog parents like @hayleyglatfelter know what it's like to rehabilitate a sick dog, but this brave woman has ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to DPTX3186, a first in class oral condensate ...

What should patients expect before undergoing Mohs surgery in Traverse City? According to a HelloNation article, Dr. Laurel ...

Skin cancer impacts millions of Americans annually, but your chances of getting skin cancer and when it is diagnosed depend ...

Enara Bio, a biopharmaceutical company pioneering the discovery of novel Dark Antigens (R) and the development of bispecific T cell engagers for solid tumors, will unveil its newly discovered ...